BRIGHT MINDS BIOSCIENCES INC. Accounting Profit
BRIGHT MINDS BIOSCIENCES INC. (DRUG) reported Accounting Profit of -CAD 2.80 million for the 12-month period ending 2024-09-30, per its 20-F filed 2024-12-31.
Financial Statements › Notes
ifrs-full:AccountingProfit · last filed 2024-12-31
| Period end | Accounting Profit 12 month |
|---|---|
| 2024-09-30 | -2.80M CAD 20-F · filed 2024-12-31 |
| 2023-09-30 | -7.37M CAD 20-F · filed 2024-12-31 |
| 2022-09-30 | -14.96M CAD 20-F · filed 2024-12-31 |
| 2021-09-30 | -8.65M CAD 20-F · filed 2023-12-29 |
| 2020-09-30 | -480.38K CAD 20-F · filed 2022-12-29 |
| 2019-09-30 | -78.72K CAD 20-F/A · filed 2022-01-18 |